307 related items for PubMed ID: 12774223
1. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
2. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
3. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
4. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Nov 01; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
6. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
7. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U, Weber LT.
Pediatr Nephrol; 2018 Dec 01; 33(12):2253-2265. PubMed ID: 29750317
[Abstract] [Full Text] [Related]
8. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul 01; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
9. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May 01; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
10. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
11. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov 23; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
12. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
Al-Akash S, Al-Makdama A.
Ann Saudi Med; 2005 Nov 23; 25(5):380-4. PubMed ID: 16270759
[Abstract] [Full Text] [Related]
13. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
Pediatr Int; 2007 Dec 23; 49(6):933-7. PubMed ID: 18045300
[Abstract] [Full Text] [Related]
14. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 23; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
15. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 23; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
16. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 23; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
17. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 Apr 23; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
Pediatr Nephrol; 2016 Nov 23; 31(11):2095-101. PubMed ID: 27263020
[Abstract] [Full Text] [Related]
19. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 23; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
20. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct 23; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
